TNM clinical stage | Cathepsin K | Total | Pearson Chi-Square Asymp. Sig. (2-sided) | |
---|---|---|---|---|
negative or weak expression | moderate or strong expression | |||
stage I + II % within TNM clinical stage | 10 | 3 | 13 | .000 |
76.9% | 23.1% | 100.0% | Â | |
stage III + IV % within TNM clinical stage | 6 | 26 | 32 | |
18.8% | 81.3% | 100.0% | Â | |
Total % within TNM clinical stage | 16 | 29 | 45 | |
35.6% | 64.4% | 100.0% | Â |